DMD and SNTG1 |
dystrophin |
syntrophin gamma 1 |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
|
|
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DMD and HAUS1 |
dystrophin |
HAUS augmin like complex subunit 1 |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- AURKA Activation by TPX2
|
|
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DMD and SNTG2 |
dystrophin |
syntrophin gamma 2 |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
|
|
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DMD and CADPS2 |
dystrophin |
calcium dependent secretion activator 2 |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
|
|
- Calcium Citrate
- Calcium Phosphate
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DMD and HNF4A |
dystrophin |
hepatocyte nuclear factor 4 alpha |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
- Nuclear Receptor transcription pathway
|
|
- Lauric Acid
- AVI-4557
- Myristic acid
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
- Maturity onset diabetes of the young (MODY)
|
DMD and SNTA1 |
dystrophin |
syntrophin alpha 1 |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
|
|
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DMD and SNTB1 |
dystrophin |
syntrophin beta 1 |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
|
|
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DMD and SNTB2 |
dystrophin |
syntrophin beta 2 |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
|
|
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DMD and MAP3K5 |
dystrophin |
mitogen-activated protein kinase kinase kinase 5 |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
- Oxidative Stress Induced Senescence
- Oxidative Stress Induced Senescence
|
|
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DMD and UTRN |
dystrophin |
utrophin |
- Non-integrin membrane-ECM interactions
- Striated Muscle Contraction
|
- EGR2 and SOX10-mediated initiation of Schwann cell myelination
|
|
|
- Glycerol kinase deficiency (GKD), including: Hyperglycerolemia; Chromosome Xp21 deletion syndrome; Adrenal hypoplasia, congenital (AHC); Duchenne muscular dystrophy (DMD)
- Dystrophinopathies, including: Duchenne muscular dystrophy (DMD); Becker muscular dystrophy (BMD); X-linked dilated cardiomyopathy (XLCM)
- Dilated cardiomyopathy (DCM)
|
|
DNMT1 and L3MBTL3 |
DNA methyltransferase 1 |
L3MBTL histone methyl-lysine binding protein 3 |
- PRC2 methylates histones and DNA
- NoRC negatively regulates rRNA expression
- SUMOylation of DNA methylation proteins
- DNA methylation
|
|
- Azacitidine
- Procainamide
- Flucytosine
- Decitabine
- Epigallocatechin Gallate
|
|
|
|
DPT and TGFB1 |
dermatopontin |
transforming growth factor beta 1 |
|
- Platelet degranulation
- Influenza Virus Induced Apoptosis
- Cell surface interactions at the vascular wall
- Molecules associated with elastic fibres
- Downregulation of TGF-beta receptor signaling
- Downregulation of TGF-beta receptor signaling
- TGF-beta receptor signaling activates SMADs
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- Syndecan interactions
- ECM proteoglycans
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- TGFBR2 MSI Frameshift Mutants in Cancer
- TGFBR2 Kinase Domain Mutants in Cancer
- TGFBR1 KD Mutants in Cancer
- TGFBR1 LBD Mutants in Cancer
- Transcriptional regulation of white adipocyte differentiation
- UCH proteinases
- Interleukin-4 and Interleukin-13 signaling
- RUNX3 regulates CDKN1A transcription
- Regulation of RUNX3 expression and activity
- RUNX3 regulates p14-ARF
|
|
- Hyaluronidase
- Hyaluronidase (Human Recombinant)
|
|
- Graft-versus-host disease
- Allograft rejection
- Camurati-Engelmann disease; Progressive diaphyseal dysplasia
|
DR1 and DRAP1 |
down-regulator of transcription 1 |
DR1 associated protein 1 |
|
- Signaling by NODAL
- Signaling by Activin
|
|
|
|
|
DRD2 and TRPC4 |
dopamine receptor D2 |
transient receptor potential cation channel subfamily C member 4 |
|
- TRP channels
- Role of second messengers in netrin-1 signaling
|
- Amphetamine
- Ziprasidone
- Cabergoline
- Ropinirole
- Olanzapine
- Clozapine
- Mirtazapine
- Thiethylperazine
- Sulpiride
- Loxapine
- Remoxipride
- Pramipexole
- Promazine
- Prochlorperazine
- Droperidol
- Imipramine
- Chlorpromazine
- Buspirone
- Haloperidol
- Triflupromazine
- Nortriptyline
- Amoxapine
- Cinnarizine
- Lisuride
- Fluphenazine
- Thioridazine
- Ergotamine
- Apomorphine
- Trimipramine
- Risperidone
- Propiomazine
- Minaprine
- Trifluoperazine
- Perphenazine
- Flupentixol
- Amantadine
- Mesoridazine
- Maprotiline
- Dopamine
- Carphenazine
- Memantine
- Ergoloid mesylate
- Acetophenazine
- Promethazine
- Pimozide
- Doxepin
- Desipramine
- Domperidone
- Pergolide
- Bromocriptine
- Ketamine
- Quetiapine
- Metoclopramide
- Levodopa
- Aripiprazole
- Chlorprothixene
- Paliperidone
- Yohimbine
- Methotrimeprazine
- Alizapride
- Rolicyclidine
- Acepromazine
- Molindone
- Pipotiazine
- Thioproperazine
- Thiothixene
- Zuclopenthixol
- Aniracetam
- Fluspirilene
- Tetrabenazine
- Brasofensine
- Bifeprunox
- Bicifadine
- Itopride
- Iloperidone
- Rotigotine
- Pimavanserin
- BL-1020
- ACP-104
- Cariprazine
- Lumateperone
- Sertindole
- Mianserin
- Asenapine
- Amisulpride
- Lurasidone
- Perospirone
- Bromopride
- Quinagolide
- Brexpiprazole
- Etoperidone
- AS-8112
- Pardoprunox
- Tetrahydropalmatine
- Piribedil
- Raclopride
- Tiapride
|
|
|
|
DRD5 and GABRG2 |
dopamine receptor D5 |
gamma-aminobutyric acid type A receptor subunit gamma2 |
- Dopamine receptors
- G alpha (s) signalling events
- ADORA2B mediated anti-inflammatory cytokines production
|
- Signaling by ERBB4
- GABA receptor activation
- GABA receptor activation
|
- Ziprasidone
- Cabergoline
- Cabergoline
- Ropinirole
- Olanzapine
- Olanzapine
- Mirtazapine
- Loxapine
- Loxapine
- Pramipexole
- Imipramine
- Chlorpromazine
- Chlorpromazine
- Cinnarizine
- Lisuride
- Ergotamine
- Apomorphine
- Trimipramine
- Fenoldopam
- Dopamine
- Dopamine
- Carphenazine
- Pergolide
- Bromocriptine
- Quetiapine
- Levodopa
- Aripiprazole
- Methotrimeprazine
- Zuclopenthixol
- Rotigotine
- Mianserin
- Quinagolide
|
- Lorazepam
- Ethchlorvynol
- Enflurane
- Temazepam
- Temazepam
- Butabarbital
- Butalbital
- Topiramate
- Etomidate
- Talbutal
- Pentobarbital
- Olanzapine
- Clobazam
- Meprobamate
- Carisoprodol
- Eszopiclone
- Alprazolam
- Zolpidem
- Metharbital
- Chlordiazepoxide
- Amoxapine
- Adinazolam
- Clorazepate
- Acamprosate
- Midazolam
- Flurazepam
- Isoflurane
- Primidone
- Halazepam
- Halazepam
- Propofol
- Diazepam
- Diazepam
- Oxazepam
- Oxazepam
- Triazolam
- Triazolam
- Methoxyflurane
- Ergoloid mesylate
- Clonazepam
- Methyprylon
- Halothane
- Desflurane
- Flumazenil
- Flumazenil
- Estazolam
- Estazolam
- Sevoflurane
- Ginkgo biloba
- Glutethimide
- Flunitrazepam
- Bromazepam
- Clotiazepam
- Fludiazepam
- Prazepam
- Prazepam
- Quazepam
- Quazepam
- Cinolazepam
- Nitrazepam
- Prasterone
- Taurine
- Adipiplon
- Stiripentol
- Etizolam
- Thiocolchicoside
- Muscimol
- Lormetazepam
|
|
- Febrile seizures, including: Febrile convulsions; Generalized epilepsy with febrile seizure plus (GEFS+); Dravet syndrome/ Severe myoclonic epilepsy in infancy (SMEI)
- Idiopathic generalied epilepsies (IGEs), including: Childhood absence epilepsy (CAE); Juvenile absence epilepsy (JAE); Juvenile myoclonic epilepsy (JME); Epilepsy with generalized tonic-clonic seizures alone
|
ATN1 and PDCD6IP |
atrophin 1 |
programmed cell death 6 interacting protein |
- Regulation of PTEN gene transcription
|
- Budding and maturation of HIV virion
- Uptake and function of anthrax toxins
|
|
|
- Dentatorubropallidoluysian atrophy (DRPLA)
|
|
E2F1 and TFDP1 |
E2F transcription factor 1 |
transcription factor Dp-1 |
- Activation of NOXA and translocation to mitochondria
- Inhibition of replication initiation of damaged DNA by RB1/E2F1
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- Activation of PUMA and translocation to mitochondria
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- Oxidative Stress Induced Senescence
- Oncogene Induced Senescence
- TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
- CDC6 association with the ORC:origin complex
- G2 Phase
- Cyclin E associated events during G1/S transition
- G1/S-Specific Transcription
- G1/S-Specific Transcription
- Cyclin D associated events in G1
- Cyclin A:Cdk2-associated events at S phase entry
- Transcriptional Regulation by E2F6
- Transcriptional regulation of granulopoiesis
- Transcriptional regulation of granulopoiesis
|
- Activation of NOXA and translocation to mitochondria
- Inhibition of replication initiation of damaged DNA by RB1/E2F1
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- Activation of PUMA and translocation to mitochondria
- G0 and Early G1
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Oxidative Stress Induced Senescence
- Oncogene Induced Senescence
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Cyclin E associated events during G1/S transition
- G1/S-Specific Transcription
- G1/S-Specific Transcription
- Cyclin D associated events in G1
- Cyclin A:Cdk2-associated events at S phase entry
- Transcriptional Regulation by E2F6
- Transcriptional regulation of granulopoiesis
- Transcriptional regulation of granulopoiesis
|
|
|
|
|
E2F2 and TFDP1 |
E2F transcription factor 2 |
transcription factor Dp-1 |
- Oxidative Stress Induced Senescence
- Oncogene Induced Senescence
- CDC6 association with the ORC:origin complex
- Cyclin D associated events in G1
|
- Activation of NOXA and translocation to mitochondria
- Inhibition of replication initiation of damaged DNA by RB1/E2F1
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- Activation of PUMA and translocation to mitochondria
- G0 and Early G1
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Oxidative Stress Induced Senescence
- Oncogene Induced Senescence
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Cyclin E associated events during G1/S transition
- G1/S-Specific Transcription
- G1/S-Specific Transcription
- Cyclin D associated events in G1
- Cyclin A:Cdk2-associated events at S phase entry
- Transcriptional Regulation by E2F6
- Transcriptional regulation of granulopoiesis
- Transcriptional regulation of granulopoiesis
|
|
|
|
|
E2F3 and TFDP1 |
E2F transcription factor 3 |
transcription factor Dp-1 |
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- Oxidative Stress Induced Senescence
- Oncogene Induced Senescence
- CDC6 association with the ORC:origin complex
- G2 Phase
- Cyclin D associated events in G1
|
- Activation of NOXA and translocation to mitochondria
- Inhibition of replication initiation of damaged DNA by RB1/E2F1
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- Activation of PUMA and translocation to mitochondria
- G0 and Early G1
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Oxidative Stress Induced Senescence
- Oncogene Induced Senescence
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Cyclin E associated events during G1/S transition
- G1/S-Specific Transcription
- G1/S-Specific Transcription
- Cyclin D associated events in G1
- Cyclin A:Cdk2-associated events at S phase entry
- Transcriptional Regulation by E2F6
- Transcriptional regulation of granulopoiesis
- Transcriptional regulation of granulopoiesis
|
|
|
|
|
E2F4 and TFDP1 |
E2F transcription factor 4 |
transcription factor Dp-1 |
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- G0 and Early G1
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Cyclin E associated events during G1/S transition
- G1/S-Specific Transcription
- G1/S-Specific Transcription
- Cyclin D associated events in G1
- Cyclin A:Cdk2-associated events at S phase entry
|
- Activation of NOXA and translocation to mitochondria
- Inhibition of replication initiation of damaged DNA by RB1/E2F1
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- Activation of PUMA and translocation to mitochondria
- G0 and Early G1
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Oxidative Stress Induced Senescence
- Oncogene Induced Senescence
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Cyclin E associated events during G1/S transition
- G1/S-Specific Transcription
- G1/S-Specific Transcription
- Cyclin D associated events in G1
- Cyclin A:Cdk2-associated events at S phase entry
- Transcriptional Regulation by E2F6
- Transcriptional regulation of granulopoiesis
- Transcriptional regulation of granulopoiesis
|
|
|
|
|